Acadia Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Summary

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) will participate in several upcoming investor conferences in September 2022. Key events include the Citi’s 17th Annual BioPharma Conference on September 8 at 1:00 p.m. ET in Boston, the Morgan Stanley 20th Annual Global Healthcare Conference on September 13 at 11:10 a.m. ET in New York, and the Cowen 2nd Annual Novel Mechanisms in Neuropsychiatry Virtual Summit on September 19 at 2:10 p.m. ET. Live webcasts will be accessible on Acadia’s website, with recordings available for one month post-event.

SAN DIEGO--(BUSINESS WIRE)-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at the following upcoming investor conferences:

Citi’s 17^th Annual BioPharma Conference
Fireside Chat: Thursday, September 8, 2022 at 1:00 p.m. Eastern Time in Boston, MA

Morgan Stanley 20^th Annual Global Healthcare Conference
Fireside Chat: Tuesday, September 13, 2022 at 11:10 a.m. Eastern Time in New York, NY

Cowen 2^nd Annual Novel Mechanisms in Neuropsychiatry Virtual Summit
Fireside Chat: Monday, September 19, 2022 at 2:10 p.m. Eastern Time

Live webcasts of the presentations will be accessible on the company’s website, www.acadia.com, under the investors section and an archived recording will be available on the website for approximately one month following each presentation.

About Acadia Pharmaceuticals
Acadia is advancing breakthroughs in neuroscience to elevate life. For more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapy for hallucinations and delusions associated with Parkinson’s disease psychosis. Our clinical-stage development efforts are focused on treating the negative symptoms of schizophrenia, Rett syndrome and neuropsychiatric symptoms in central nervous system disorders. For more information, visit us at www.acadia.com and follow us on LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220901005268/en/

Media Contact:

Acadia Pharmaceuticals Inc.

Deb Kazenelson

(818) 395-3043

media@acadia-pharm.com



Investor Contact:

Acadia Pharmaceuticals Inc.

Mark Johnson, CFA

(858) 261-2771

ir@acadia-pharm.com

Source: Acadia Pharmaceuticals Inc.

FAQ

What conferences will Acadia Pharmaceuticals participate in September 2022?

Accadia Pharmaceuticals will participate in Citi’s 17th Annual BioPharma Conference on September 8, Morgan Stanley's Global Healthcare Conference on September 13, and Cowen's Neuropsychiatry Virtual Summit on September 19.

What is the schedule for Acadia Pharmaceuticals' investor conferences?

The schedule includes Citi’s BioPharma Conference on September 8 at 1:00 p.m. ET, Morgan Stanley's Healthcare Conference on September 13 at 11:10 a.m. ET, and Cowen’s Neuropsychiatry Summit on September 19 at 2:10 p.m. ET.

Where can I watch the Acadia Pharmaceuticals conference webcasts?

Live webcasts of Acadia Pharmaceuticals' presentations will be available on their website in the investors section.

How long will the conference recordings be available for Acadia Pharmaceuticals?

Recordings of Acadia Pharmaceuticals' conference presentations will be accessible for approximately one month following each event.

What is the significance of Acadia Pharmaceuticals attending these conferences?

Acadia Pharmaceuticals' participation in these conferences highlights its commitment to investor relations and showcases its advances in neuroscience.